Cigna Corporation (CI) Stake Lifted by Toronto Dominion Bank
Toronto Dominion Bank lifted its holdings in Cigna Corporation (NYSE:CI) by 25.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86,740 shares of the health services provider’s stock after purchasing an additional 17,348 shares during the quarter. Toronto Dominion Bank’s holdings in Cigna Corporation were worth $14,517,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also bought and sold shares of the company. American Beacon Advisors Inc. purchased a new position in shares of Cigna Corporation in the first quarter worth $102,000. Capstone Investment Advisors Netherlands B.V. purchased a new position in shares of Cigna Corporation in the second quarter worth $106,000. Parallel Advisors LLC raised its stake in shares of Cigna Corporation by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after purchasing an additional 307 shares during the last quarter. Guardian Life Insurance Co. of America raised its stake in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after purchasing an additional 7 shares during the last quarter. Finally, Acrospire Investment Management LLC raised its stake in shares of Cigna Corporation by 66.7% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock worth $167,000 after purchasing an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 87.94% of the company’s stock.
Shares of Cigna Corporation (NYSE:CI) traded down 0.43% during mid-day trading on Friday, hitting $186.15. The company had a trading volume of 1,974,110 shares. The company has a 50-day moving average price of $185.32 and a 200-day moving average price of $170.30. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $193.00. The company has a market capitalization of $46.87 billion, a price-to-earnings ratio of 21.48 and a beta of 0.43.
Cigna Corporation (NYSE:CI) last issued its earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the business posted $1.98 EPS. On average, equities analysts anticipate that Cigna Corporation will post $10.03 EPS for the current year.
TRADEMARK VIOLATION WARNING: This news story was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://theolympiareport.com/2017/10/15/cigna-corporation-ci-stake-lifted-by-toronto-dominion-bank.html.
Several research firms have recently weighed in on CI. Jefferies Group LLC boosted their price target on Cigna Corporation from $201.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday. Zacks Investment Research upgraded Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price target for the company in a research note on Monday, October 9th. Piper Jaffray Companies restated a “buy” rating and issued a $191.00 price target on shares of Cigna Corporation in a research note on Sunday, September 17th. BidaskClub upgraded Cigna Corporation from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 18th. Finally, Morgan Stanley boosted their price target on Cigna Corporation from $188.00 to $195.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. One research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $192.33.
In other Cigna Corporation news, VP Mary T. Hoeltzel sold 525 shares of Cigna Corporation stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $177.59, for a total transaction of $93,234.75. Following the completion of the transaction, the vice president now owns 1,924 shares in the company, valued at approximately $341,683.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jason D. Sadler sold 37,756 shares of Cigna Corporation stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $176.16, for a total value of $6,651,096.96. Following the transaction, the insider now owns 47,844 shares of the company’s stock, valued at approximately $8,428,199.04. The disclosure for this sale can be found here. Insiders have sold a total of 70,653 shares of company stock valued at $12,437,684 in the last quarter. Company insiders own 1.30% of the company’s stock.
Cigna Corporation Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.